Total
0
Shares
Advanced Human Imaging (ASX:AHI) - CEO Vlado Bosanac - The Market Herald
CEO Vlado Bosanac
Source: The Big Smoke
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Medical imaging company Advanced Human Imaging (AHI) is one step closer to purchasing Israeli-based musculoskeletal assessment company Physimax Technologies
  • Under a binding heads of agreement, AHI will now undergo its due diligence processes, which are expected to be completed next month
  • If all conditions are met, AHI will pay an all-share consideration worth US$6 million (around A$7.74 million) for Physimax as well as an additional US$2 million (about A$2.58 million) as part of an earn-in agreement
  • Physimax has developed a video-based solution that tracks and improves musculoskeletal wellness and performance by analysing the condition using a mobile device
  • Notably, Physimax has been chosen by top healthcare providers, elite sporting organisations, such as NFL and NBL, U.S. military units and colleges
  • On the market this morning, AHI is down 1.63 per cent and is trading at $1.81 per share

Advanced Human Imaging (AHI) is one step closer to purchasing Israeli-based musculoskeletal assessment company Physimax Technologies.

Last week, the parties announced the proposed acquisition with a letter of intent.

Today, a binding heads of agreement has been executed under which AHI will conduct due diligence on Physimax, which it expects to complete around May 21, 2021.

If all conditions are met, AHI will pay an all-share consideration worth US$6 million (around A$7.74 million) for Physimax, as well as an additional US$2 million (about A$2.58 million) as part of an earn-in agreement.

Physimax has developed a video-based solution that tracks and improves musculoskeletal wellness and performance by analysing the condition using a mobile device.

Its technology automatically measures and scores mobility, stability, strength, and movement control according to evidence-based body movement patterns.

Additionally, the technology will then provide a personalised workout program for each individual.

The machine learning technology is commercially available for healthy individuals and patients undergoing rehabilitation.

Notably, Physimax has been chosen by top healthcare providers, elite sporting organisations, such as NFL and NBL, U.S. military units and colleges.

"The musculoskeletal assessment space is seeing accelerated interest, with a number of insurance and care-based platforms having adopted Musculoskeletal assessment, being Dario Health, Hinge Health and Carrum Health, all now adding offerings within their customer care initiatives," AHI CEO and Chairman Vlado Bosanac said.

"With the AHI on device 2D/3D capturing capabilities of our patented system, we anticipate that, should the acquisition proceed, we will further enhance the Physimax system in readiness for a global approach to these new capabilities," he added.

Musculoskeletal issues include more than 150 conditions that affect the locomotor system of individuals. These include short-term conditions — such as fractures, sprains and strains — to lifelong conditions associated with ongoing limitations and disability.

Importantly, musculoskeletal conditions are the highest contributor to the global need for rehabilitation.

"AHI will continue to identify opportunities of this kind that are complementary to the AHI offering, with a view to either a partnership, or when advantageous, acquisition," Vlado concluded.

On the market this morning, AHI is down 1.63 per cent and is trading at $1.81 per share at 10:43 am AEST.

AHI by the numbers
More From The Market Herald
Gabon-focussed iron ore company Genmin (ASX:GEN) lists on ASX

" Argenica Therapeutics (ASX:AGN) lists on ASX

Argenica Therapeutics (AGN) has finished its first day of trade on the ASX, following a well supported initial public offering.
Creso Pharma (ASX:CPH) - Creso Pharma - The Market Herald

" Creso Pharma (ASX:CPH) completes US dual listing

Creso Pharma (CPH) is officially dual listed, after completing its listing on the US OTCQB stock exchange.
The Market Herald Video

" US regulator approves expanded use of Avita Medical’s (ASX:AVH) RECELL System

The US regulator has approved the expanded use of Avita Medical’s (AVH) RECELL system in combination with meshed autographs to treat burns patients.
Advanced Human Imaging (ASX:AHI) - CEO, Vlado Bosanac - The Market Herald

" Advanced Human Imaging (ASX:AHI) signs term sheet with Cubert

Advanced Human Imaging (AHI) has signed a binding term sheet with Toronto-based digital health provider Cubert Inc.